WallStreetZenWallStreetZen

NASDAQ: ZNTL
Zentalis Pharmaceuticals Inc Stock Ownership - Who owns Zentalis Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Zentalis Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Scott Dunseth MyersDirector2025-04-3021,000$1.40
$29.38kBuy
Ingmar BrunsChief Medical Officer2025-02-0620,000$2.28
$45.66kBuy
Andrea PaulChief Legal Officer2025-02-0313,230$1.71
$22.65kSell
Mark LacknerChief Scientific Officer2025-02-0314,368$1.71
$24.60kSell
Vincent VultaggioPAO and Interim PFO2025-02-032,615$1.71
$4.48kSell
Jan SkvarkaDirector2025-01-3160,000$1.72
$103.44kBuy
Luke Nathaniel WalkerDirector2025-01-3114,200$1.76
$24.96kBuy
Julia Marie EastlandCEO President2025-01-3128,500$1.73
$49.33kBuy
Mark LacknerChief Scientific Officer2025-01-024,411$3.12
$13.76kSell

1 of 1

ZNTL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ZNTL insiders and whales buy or sell their stock.

ZNTL Shareholders

What type of owners hold Zentalis Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Matrix Capital Management Company LP19.35%13,959,973$23.87MInsider
Matrix Capital Management Company LP19.35%13,959,973$23.87MInstitution
Viking Global Investors LP5.47%3,943,284$6.74MInsider
David E. Goel5.30%3,821,739$6.54MInsider
Anthony Y. Sun5.24%3,780,043$6.46MInsider
Millennium Management LLC4.82%3,476,808$5.95MInstitution
Vanguard Group Inc4.00%2,884,632$4.93MInstitution
Acadian Asset Management LLC3.88%2,799,020$4.79MInstitution
Opaleye Management Inc2.67%1,924,300$3.29MInstitution
Blackrock Inc2.41%1,741,747$2.98MInstitution

1 of 3

ZNTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZNTL63.87%36.13%Net Buying
ANEB41.29%58.71%Net Buying
TCRX62.95%29.87%Net Buying
ATOS16.53%11.04%Net Buying
ARTV54.17%45.83%Net SellingNet Selling
View Top Biotech Stocks

Zentalis Pharmaceuticals Stock Ownership FAQ

Who owns Zentalis Pharmaceuticals?

Zentalis Pharmaceuticals (NASDAQ: ZNTL) is owned by 77.15% institutional shareholders, 43.65% Zentalis Pharmaceuticals insiders, and 0.00% retail investors. Matrix Capital Management Company LP is the largest individual Zentalis Pharmaceuticals shareholder, owning 13.96M shares representing 19.35% of the company. Matrix Capital Management Company LP's Zentalis Pharmaceuticals shares are currently valued at $21.36M.

If you're new to stock investing, here's how to buy Zentalis Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.